CTRI/2014/01/004295已完成未知
Modified Human Repeat Insult Patch Test - HRIPT -01-13
Johnson Johnson0 个研究点目标入组 210 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female subjects 18 to 65 years of age of Indian Race.
- •Subjects must be generally in good health as determined from a recent medical history which is on file with the investigator.
- •The ability of the subject to understand and sign a written informed consent form which must be obtained prior to treatment.
- •Willingness to avoid the use of topical products at the test sites during the study.
- •Willingness to avoid direct sun exposure to the test sites for the duration of the study.
排除标准
- •Individuals with active or history of psoriasis, active allergic skin responses, or active eczema as determined by the initial paperwork. Individuals with a history of eczema will be allowed on the study, as long as they complete a supplemental consent form.
- •Individuals with sunburn, acne, abrasions, scar tissue, or tattoos on the test sites, or diseases of the skin that might interfere with the evaluation made in this study or that expose study participants to unacceptable risks.
- •Women known to be pregnant, nursing, or planning to become pregnant during the study as determined by the initial paperwork.
- •Use of topical steroids and/or drugs at test sites as determined by the initial paperwork.
- •Current routine or frequent use of high doses of anti-inflammatory drugs for a defined medical condition as determined by the initial paperwork. Aspirin use should not exceed two tablets (650 mg) daily.
- •Individuals who had less than a two week rest period since completion of any previous patch testing.
- •Individuals with uncontrolled metabolic diseases such as hypertension, hyperthyroidism, hypothyroidism, diabetes, etc.
- •Individuals who had a mastectomy in which axillary nodes were removed as determined by the initial paperwork.
- •Individuals currently receiving any anticancer, immunosuppressive treatments/medications, and/or radiation as determined by the initial paperwork.
- •Active or untreated skin cancer as determined by the initial paperwork.
- •Previous clinically determined allergic reaction on a patch study, or known sensitivities or allergies to personal care products of any type.
- •Individuals will be admitted to the study at the discretion of the Investigator based on medical history and findings of the pre-study interview and examination.
研究者
相似试验
已完成
2 期
Modified Human Repeat Insult Patch TestCTRI/2012/10/003053Johnson and Johnson110
已完成
不适用
To check is the test product is causing irritation or allergy in men/women after repeated applications of patch.CTRI/2020/09/027828Cipla Ltd55
已完成
不适用
To determine whether the test product is causing irritation or allergy in human participants after repeated applications of patchCTRI/2018/07/014741Amishi Consumer Technologies Private Limited230
已完成
不适用
Skin sensitivity test to evaluate sensitization of test products.CTRI/2013/02/003371Johnson Johnson110
进行中（未招募）
1 期
Human Repeat Insult Patch Test with Challengeot Applicable (Healthy Volunteer Study)EUCTR2004-004830-15-GBStiefel Laboratories Maidenhead Ltd (commonly known as Stiefel International R&D)110